However, from a prognostic perspective, CD5, SLCO1B1, and CD79A have been demonstrated to have protective value in various tumors, whereas ETV5, FZD7, SNX7, and SLC1A7 are involved in tumor progression. Here, ETV5 is linked to neoplasm.